USX:ARTLW - Artelo Biosciences Inc Artelo Biosciences Inc
Sector: Unknown, Industry: Unknown
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 0.236    -0.014 (-5.64%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

10 Sep 2021


Loading...
Loading...
Loading...

General

IPO: 2019-06-21

Headquarters: US

Employees: 1

Description

Artelo Biosciences, Inc., an ethical biopharmaceutical company, focuses on developing, licensing, and commercializing cannabinoid therapeutic treatments. Its products pipeline includes ART12.11, a cannabidiol composition for the treatment of inflammatory bowel disease, stroke, and rare/orphan diseases; ART26.12, an endocannabinoid transport protein (FABP5) inhibitor for the treatment of breast cancer, prostate cancer, and neuropathic and nociceptive pain; and ART27.13 for the treatment of cancer and cachexia. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was founded in 2011 and is based in La Jolla, California.